iCoreConnect Inc. Announces Additions to Its Board of Directors

Rhea-AI Summary

iCoreConnect announces the addition of Dr. John Pasqual and Joseph Gitto to its Board of Directors. They will also serve on the Audit, Compensation, and Nomination and Governance Committees. The company is excited about their extensive experience and diverse backgrounds.

Positive

• The addition of Dr. John Pasqual and Joseph Gitto brings valuable expertise to iCoreConnect's Board of Directors, which can contribute to the company's growth and leadership position in the healthcare technology industry.

Negative

• None.

iCoreConnect Brings Extensive Medical, Finance and Operational Experience to Its Board With the Addition of Dr. John Pasqual & Joseph Gitto

OCOEE, FL, Aug. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – iCoreConnect, Inc. (OTCQB: ICCT) (“iCore” or the “Company”), a leading cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise and healthcare workflow platform, today announced the appointments of  Dr. John Pasqual and Joseph Gitto to its Board of Directors. Dr. Pasqual and Mr. Gitto will also serve on the Audit, Compensation, and Nomination and Governance Committees of the Board.

Robert McDermott, Chairman of the Board, President and Chief Executive Officer of iCoreConnect, stated, "We are thrilled to welcome John and Joe to our Board of Directors. Their extensive experience and diverse backgrounds will be invaluable to the Company as we continue to grow and advance our leadership position in the healthcare technology industry."

Dr. Pasqual commented, “iCoreConnect’s brand recognition in the healthcare SaaS sector, cutting-edge technology and significant growth opportunity is very exciting, and I look forward to working with Robert and the rest of the team to execute against the Company’s strategic growth objectives.”

Mr. Gitto stated, “I am pleased to join iCoreConnect’s Board of Directors and am looking forward to being a part of a recognized leading company that is at the forefront of SaaS solutions for enterprises across the healthcare industry, with a proven go-to-market strategy.”

About Dr. John Pasqual

John R. Pasqual, D.M.D., P.A. is a board-certified oral and maxillofacial surgeon and fellow of the American Association of Oral and Maxillofacial Surgeons and a Diplomate of the American Board of Oral and Maxillofacial Surgery. He is also a Diplomate of the International Congress of Oral Implantologist and Diplomate of the National Dental Board of Anesthesiology. Dr. Pasqual is on staff and provides trauma call for Bethesda Memorial Hospital in Southwest Florida. Dr. Pasqual has published in numerous journals such as Plastic and Reconstructive Surgery, Anesthesiology as well as Anesthesia and Analgesia. He graduated from the University of Pittsburgh School of Dental Medicine in 1997, where he served as class President. Dr. Pasqual received post-graduate training in surgery as well as anesthesia at Case Western Reserve University’s MetroHealth Medical Center, a level I trauma center located in Cleveland, Ohio, where he served as chief resident.

About Mr. Joseph Gitto

Mr. Gitto is an accomplished senior finance, sales, and operational executive, entrepreneur, coach, thought leader, and board member with more than 25 years of success in various industries covering both public and private entities. From January 2012 until March 2019, Mr. Gitto served as co-owner, President, Chief Financial Officer, and Director of Sales of BrightStar Home Health Care, a franchise that provides home skilled and non-skilled care to seniors and pediatrics. Mr. Gitto graduated from Baruch College with a BS in Accounting & Finance and received his Certificate in Financial Planning from the University of Florida.  He is also a Certified Exit Planning Advisor (CEPA) and an Investment Advisor (FINRA).

Forward-Looking Statements

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the Company’s revenue and annualized recurring revenue estimates for 2023, the Company’s ability to grow opportunities within ePrescription and insurance verification, and the Company's ability to continue to expand its reach into medical customers. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. The Company has attempted to identify forward-looking statements by terminology including ‘believes,’ ‘estimates,’ ‘anticipates,’ ‘expects,’ ‘plans,’ ‘projects,’ ‘intends,’ ‘potential,’ ‘may,’ ‘could,’ ‘might,’ ‘will,’ ‘should,’ ‘approximately’ or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. “Risk Factors” in the Company’s most recently filed Form 10-K filed with the Securities and Exchange Commission (“SEC”) and updated from time to time in its Form 10-Q filings and in its other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. The Company undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

About iCoreConnect

iCoreConnect, Inc. is a market-leading cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise and healthcare workflow platform of applications and services. iCoreConnect is most notably known for its innovation in solving healthcare business problems. iCoreConnect’s philosophy places a high value on customer feedback, allowing iCoreConnect to respond to the market’s needs. iCoreConnect touts a platform of 16 SaaS enterprise solutions and more than 100 agreements with state or regional healthcare associations across the United States.

Investor Contact:
iCoreConnect
IR@iCoreConnect.com
888.810.7706, Option 6

FAQ

Who are the new members added to iCoreConnect's Board of Directors?

Dr. John Pasqual and Joseph Gitto.

What committees will Dr. Pasqual and Mr. Gitto serve on?

Audit, Compensation, and Nomination and Governance Committees.

What is iCoreConnect's focus?

iCoreConnect is a cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise and healthcare workflow platform.